Moderna becomes the first company to have positive information about its SARS-COV2 vaccine published in a peer-reviewed journal. The New England Journal of Medicine published a preliminary report which has some positive information. As the R-0 of the virus continues to rise in this part of the Pandemic, many epidemiologists and virologists say that a … Continue reading New England Journal of Medicine publishes the preliminary Phase I results of the Moderna mRNA SARS-COV2 Vaccine.